These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18946091)

  • 1. Nuchal translucency quality monitoring holes in the safety net.
    Wax JR; Pinette MG
    J Ultrasound Med; 2008 Nov; 27(11):1539-42. PubMed ID: 18946091
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality management of nuchal translucency ultrasound measurement in Australia.
    Nisbet D; Robertson A; Mannil B; Pincham V; Mclennan A
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):54-58. PubMed ID: 29469171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance.
    Evans MI; Krantz DA; Hallahan TW; Sherwin J
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):181-4. PubMed ID: 21484907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of nuchal transluccency measurements: an exploratory study into their performance and evaluation].
    van den Berg M; Kleinveld JH; Sander MJ; van Vugt JM; Timmermans DR
    Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1691-6. PubMed ID: 16104116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The science and art of quality in obstetric ultrasound.
    Salomon LJ; Ville Y
    Curr Opin Obstet Gynecol; 2009 Apr; 21(2):153-60. PubMed ID: 19300252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
    D'Alton ME; Cleary-Goldman J; Lambert-Messerlian G; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; Dukes K; Canick JA; Malone FD
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):142-6. PubMed ID: 19173241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RETIRED: Fetal soft markers in obstetric ultrasound.
    Van den Hof MC; Wilson RD; ;
    J Obstet Gynaecol Can; 2005 Jun; 27(6):592-636. PubMed ID: 16100637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuchal translucency quality monitoring: the transition from research to clinical care.
    D'Alton ME
    Obstet Gynecol; 2010 Oct; 116(4):806-807. PubMed ID: 20859140
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation of a national nuchal translucency education and quality monitoring program.
    D'Alton ME; Fuchs KM; Abuhammad A; Benacerraf B; Berkowitz R; Cuckle H; Depp R; Goldberg J; O'Keeffe D; Platt LD; Spitz JL; Toland G; Wapner R;
    Obstet Gynecol; 2014 Jan; 123(1):149-154. PubMed ID: 24463675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality Requirements for the early Fetal Ultrasound Assessment at 11-13+6 Weeks of Gestation (DEGUM Levels II and III).
    von Kaisenberg C; Chaoui R; Häusler M; Kagan KO; Kozlowski P; Merz E; Rempen A; Steiner H; Tercanli S; Wisser J; Heling KS
    Ultraschall Med; 2016 Jun; 37(3):297-302. PubMed ID: 27093520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do clinical practitioners seeking credentialing for nuchal translucency measurement demonstrate compliance with biosafety recommendations? Experience of the Nuchal Translucency Quality Review Program.
    Bromley B; Spitz J; Fuchs K; Thornburg LL
    J Ultrasound Med; 2014 Jul; 33(7):1209-14. PubMed ID: 24958407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonologist's characteristics related to a higher quality in fetal nuchal translucency measured in primary antenatal care centers.
    Torrent A; Manrique G; Gómez-Castelló T; Baldrich E; Cahuana M; Manresa JM; Borrell A
    Prenat Diagn; 2019 Sep; 39(10):934-939. PubMed ID: 31237971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undermeasurement of nuchal translucencies: implications for screening.
    Evans MI; Krantz DA; Hallahan TW; Sherwin JE
    Obstet Gynecol; 2010 Oct; 116(4):815-818. PubMed ID: 20859143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of first-trimester measurement of crown-rump length.
    Dhombres F; Khoshnood B; Bessis R; Fries N; Senat MV; Jouannic JM
    Am J Obstet Gynecol; 2014 Dec; 211(6):672.e1-5. PubMed ID: 24912098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Education and quality review for nuchal translucency ultrasound.
    D'Alton ME; Cleary-Goldman J
    Semin Perinatol; 2005 Dec; 29(6):380-5. PubMed ID: 16533651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-automated measurement of nuchal translucency thickness: blasphemy or oblation to quality?
    Ville Y
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):400-3. PubMed ID: 20872935
    [No Abstract]   [Full Text] [Related]  

  • 18. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the fetal heart at 14 to 18 weeks' gestation in fetuses with a screening nuchal translucency greater than or equal to the 95th percentile.
    Foy PM; Wheller JJ; Samuels P; Evans KD
    J Ultrasound Med; 2013 Oct; 32(10):1713-9. PubMed ID: 24065251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice. Prenatal screening for aneuploidy.
    Driscoll DA; Gross S
    N Engl J Med; 2009 Jun; 360(24):2556-62. PubMed ID: 19516035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.